DOI: 10.1055/s-00000088

TumorDiagnostik & Therapie

References

Gettinger SN, Horn L, Gandhi L et al.
Overall Survival and Long-Term Safety of Nivolumab (Anti-Programmed Death 1 Antibody, BMS-936558, ONO-4538) in Patients With Previously Treated Advanced Non-Small-Cell Lung Cancer.

J Clin Oncol 2015;
33: 2004-2012

Download Bibliographical Data

Search in:
Access: